<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31439899</PMID><DateCompleted><Year>2020</Year><Month>10</Month><Day>20</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Aug</Month><Day>22</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Body weight variation predicts disease progression after invasive ventilation in amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>12262</StartPage><MedlinePgn>12262</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">12262</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-019-48831-9</ELocationID><Abstract><AbstractText>Weight loss is an independent predictor of survival in the early stages of amyotrophic lateral sclerosis (ALS). However, the effects of weight variations on the functional prognosis after tracheostomy and invasive ventilation (TIV) in ALS remain unknown. This prospective cohort study aimed to investigate the relationship between weight loss before TIV and disease progression after TIV in ALS patients. Sixty ALS patients with TIV were enrolled and classified into subgroups based on the rate of decline in body mass index, from onset to TIV utilization (&#x394;BMI). During follow-up, we assessed the patients for presence of communication impairments, ophthalmoplegia, total quadriplegia, mouth opening disability, and dysuria. We analyzed the relationship between &#x394;BMI and the communication stage or motor disabilities. The log-rank test showed that patients with a &#x394;BMI&#x2009;&#x2265;&#x2009;1.7&#x2009;kg/m<sup>2</sup>/year showed a shorter period of preserved communication ability (p&#x2009;=&#x2009;0.0001), shorter time to develop ophthalmoplegia (p&#x2009;=&#x2009;0.0001), total quadriplegia (p&#x2009;&lt;&#x2009;0.0001), mouth opening disability (p&#x2009;&lt;&#x2009;0.0001), and dysuria (p&#x2009;=&#x2009;0.0455). Cox multivariate analyses showed that a larger &#x394;BMI was an independent prognostic factor for the early development of ophthalmoplegia (p&#x2009;=&#x2009;0.0400) and total quadriplegia (p&#x2009;=&#x2009;0.0445). Weight loss in the early stages of ALS predicts disease progression in patients with advanced stages of ALS using TIV.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nakayama</LastName><ForeName>Yuki</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>ALS Nursing Care Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shimizu</LastName><ForeName>Toshio</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurology, Tokyo Metropolitan Neurological Hospital, Tokyo, Japan. toshio_shimizu@tmhp.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsuda</LastName><ForeName>Chiharu</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>ALS Nursing Care Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haraguchi</LastName><ForeName>Michiko</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>ALS Nursing Care Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hayashi</LastName><ForeName>Kentaro</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, Tokyo Metropolitan Neurological Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bokuda</LastName><ForeName>Kota</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, Tokyo Metropolitan Neurological Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nagao</LastName><ForeName>Masahiro</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Tokyo Metropolitan Neurological Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kawata</LastName><ForeName>Akihiro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Tokyo Metropolitan Neurological Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ishikawa-Takata</LastName><ForeName>Kazuko</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Nutrition and Metabolism, National Institutes of Biomedical Innovation, Health and Nutrition, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Isozaki</LastName><ForeName>Eiji</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>ALS Nursing Care Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>08</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015992" MajorTopicYN="N">Body Mass Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018572" MajorTopicYN="N">Disease-Free Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="Y">Respiration, Artificial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015431" MajorTopicYN="Y">Weight Loss</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>5</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>8</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31439899</ArticleId><ArticleId IdType="pmc">PMC6706382</ArticleId><ArticleId IdType="doi">10.1038/s41598-019-48831-9</ArticleId><ArticleId IdType="pii">10.1038/s41598-019-48831-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kiernan MC, et al. Amyotrophic lateral sclerosis. Lancet. 2011;377:942&#x2013;955. doi: 10.1016/S0140-6736(10)61156-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61156-7</ArticleId><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahrizaila N, et al. Amyotrophic lateral sclerosis and motor neuron syndromes in Asia. J. Neurol. Neurosurg. Psychiatry. 2016;87:821&#x2013;830. doi: 10.1136/jnnp-2015-312751.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2015-312751</ArticleId><ArticleId IdType="pubmed">27093948</ArticleId></ArticleIdList></Reference><Reference><Citation>Dreyer P, Lorenzen CK, Schou L, Felding M. Survival in ALS with home mechanical ventilation non-invasively and invasively: a 15-year cohort study in west Denmark. Amyotroph. Lateral Scler. Frontotemporal Degener. 2014;15:62&#x2013;67. doi: 10.3109/21678421.2013.837929.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.837929</ArticleId><ArticleId IdType="pubmed">24067168</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirose T, et al. Clinical characteristics of long-term survival with noninvasive ventilation and factors affecting the transition to invasive ventilation in amyotrophic lateral sclerosis. Muscle Nerve. 2018;58:770&#x2013;776. doi: 10.1002/mus.26149.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26149</ArticleId><ArticleId IdType="pubmed">29679377</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakayama Y, et al. Predictors of impaired communication in amyotrophic lateral sclerosis patients with tracheostomy-invasive ventilation. Amyotroph. Lateral Scler. Frontotemporal Degener. 2015;17:38&#x2013;46. doi: 10.3109/21678421.2015.1055276.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1055276</ArticleId><ArticleId IdType="pubmed">26121169</ArticleId></ArticleIdList></Reference><Reference><Citation>Tagami M, et al. Tracheostomy and invasive ventilation in Japanese ALS patients: decision-making and survival analysis: 1990-2010. J. Neurol. Sci. 2014;344:158&#x2013;164. doi: 10.1016/j.jns.2014.06.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2014.06.047</ArticleId><ArticleId IdType="pubmed">25017882</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed RM, et al. Cognition and eating behavior in amyotrophic lateral sclerosis: effect on survival. J. Neurol. 2016;263:1593&#x2013;1603. doi: 10.1007/s00415-016-8168-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-016-8168-2</ArticleId><ArticleId IdType="pubmed">27260291</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A, et al. Prognostic factors in ALS: A critical review. Amyotroph. Lateral Scler. 2009;10:310&#x2013;323. doi: 10.3109/17482960802566824.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960802566824</ArticleId><ArticleId IdType="pmc">PMC3515205</ArticleId><ArticleId IdType="pubmed">19922118</ArticleId></ArticleIdList></Reference><Reference><Citation>Enache I, et al. Ability of pulmonary function decline to predict death in amyotrophic lateral sclerosis patients. Amyotroph. Lateral Scler. Frontotemporal Degener. 2017;18:511&#x2013;518. doi: 10.1080/21678421.2017.1353097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1353097</ArticleId><ArticleId IdType="pubmed">28728441</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura F, et al. Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology. 2006;66:265&#x2013;267. doi: 10.1212/01.wnl.0000194316.91908.8a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000194316.91908.8a</ArticleId><ArticleId IdType="pubmed">16434671</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuda C, Shimizu T, Nakayama Y, Haraguchi M. Cough peak flow decline rate predicts survival in patients with amyotrophic lateral sclerosis. Muscle Nerve. 2019;59:168&#x2013;173. doi: 10.1002/mus.26320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26320</ArticleId><ArticleId IdType="pubmed">30106482</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanai K, et al. Motor axonal excitability properties are strong predictors for survival in amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 2012;83:734&#x2013;738. doi: 10.1136/jnnp-2011-301782.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2011-301782</ArticleId><ArticleId IdType="pubmed">22566594</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibuya K, et al. Motor cortical function determines prognosis in sporadic ALS. Neurology. 2016;87:513&#x2013;520. doi: 10.1212/WNL.0000000000002912.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000002912</ArticleId><ArticleId IdType="pubmed">27402895</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu T, et al. Sensory cortex hyperexcitability predicts short survival in amyotrophic lateral sclerosis. Neurology. 2018;90:e1578&#x2013;e1587. doi: 10.1212/WNL.0000000000005424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000005424</ArticleId><ArticleId IdType="pubmed">29602913</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu T, et al. Complex fasciculation potentials and survival in amyotrophic lateral sclerosis. Clin. Neurophysiol. 2014;125:1059&#x2013;1064. doi: 10.1016/j.clinph.2013.10.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2013.10.052</ArticleId><ArticleId IdType="pubmed">24345314</ArticleId></ArticleIdList></Reference><Reference><Citation>Desport JC, et al. Nutritional status is a prognostic factor for survival in ALS patients. Neurology. 1999;53:1059&#x2013;1063. doi: 10.1212/WNL.53.5.1059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.53.5.1059</ArticleId><ArticleId IdType="pubmed">10496266</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin B, et al. Alteration of nutritional status at diagnosis is a prognostic factor for survival of amyotrophic lateral sclerosis patients. J. Neurol. Neurosurg. Psychiatry. 2011;82:628&#x2013;634. doi: 10.1136/jnnp.2010.211474.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.211474</ArticleId><ArticleId IdType="pubmed">21097551</ArticleId></ArticleIdList></Reference><Reference><Citation>Paganoni S, Deng J, Jaffa M, Cudkowicz ME, Wills AM. Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis. Muscle Nerve. 2011;44:20&#x2013;24. doi: 10.1002/mus.22114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.22114</ArticleId><ArticleId IdType="pmc">PMC4441750</ArticleId><ArticleId IdType="pubmed">21607987</ArticleId></ArticleIdList></Reference><Reference><Citation>Moglia C, et al. Early weight loss in amyotrophic lateral sclerosis: outcome relevance and clinical correlates in a population-based cohort. J. Neurol. Neurosurg. Psychiatry. 2019;90:666&#x2013;673. doi: 10.1136/jnnp-2018-319611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-319611</ArticleId><ArticleId IdType="pubmed">30630957</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu T, et al. Reduction rate of body mass index predicts prognosis for survival in amyotrophic lateral sclerosis: a multicenter study in Japan. Amyotroph. Lateral Scler. 2012;13:363&#x2013;366. doi: 10.3109/17482968.2012.678366.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2012.678366</ArticleId><ArticleId IdType="pubmed">22632442</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu T, et al. Prognostic significance of body weight variation after diagnosis in ALS: a single-centre prospective cohort study. J. Neurol. 2019;266:1412&#x2013;1420. doi: 10.1007/s00415-019-09276-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-019-09276-2</ArticleId><ArticleId IdType="pubmed">30868220</ArticleId></ArticleIdList></Reference><Reference><Citation>Jesus P, et al. Hypermetabolism is a deleterious prognostic factor in patients with amyotrophic lateral sclerosis. Eur. J. Neurol. 2018;25:97&#x2013;104. doi: 10.1111/ene.13468.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.13468</ArticleId><ArticleId IdType="pubmed">28940704</ArticleId></ArticleIdList></Reference><Reference><Citation>Steyn FJ, et al. Hypermetabolism in ALS is associated with greater functional decline and shorter survival. J. Neurol. Neurosurg. Psychiatry. 2018;89:1016&#x2013;1023. doi: 10.1136/jnnp-2017-317887.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-317887</ArticleId><ArticleId IdType="pmc">PMC6166607</ArticleId><ArticleId IdType="pubmed">29706605</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakayama Y, et al. Non-motor manifestations in ALS patients with tracheostomy and invasive ventilation. Muscle Nerve. 2018;57:735&#x2013;741. doi: 10.1002/mus.26004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26004</ArticleId><ArticleId IdType="pubmed">29105161</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL. &amp; El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 2000;1:293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim WK, et al. Study of 962 patients indicates progressive muscular atrophy is a form of ALS. Neurology. 2009;73:1686&#x2013;1692. doi: 10.1212/WNL.0b013e3181c1dea3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181c1dea3</ArticleId><ArticleId IdType="pmc">PMC2788803</ArticleId><ArticleId IdType="pubmed">19917992</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi K, et al. Communication disorder in amyotrophic lateral sclerosis after ventilation&#x2013;a proposal of staging and a study of predictive factor. Rinsho Shinkeigaku. 2013;53:98&#x2013;103. doi: 10.5692/clinicalneurol.53.98.</Citation><ArticleIdList><ArticleId IdType="doi">10.5692/clinicalneurol.53.98</ArticleId><ArticleId IdType="pubmed">23470888</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum JM, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III) J. Neurol. Sci. 1999;169:13&#x2013;21. doi: 10.1016/S0022-510X(99)00210-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(99)00210-5</ArticleId><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Norris FH, Jr., Calanchini PR, Fallat RJ, Panchari S, Jewett B. The administration of guanidine in amyotrophic lateral sclerosis. Neurology. 1974;24:721&#x2013;728. doi: 10.1212/WNL.24.8.721.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.24.8.721</ArticleId><ArticleId IdType="pubmed">4858705</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi H, Kato S. Total manifestations of amyotrophic lateral sclerosis. ALS in the totally locked-in state. J. Neurol. Sci. 1989;93:19&#x2013;35. doi: 10.1016/0022-510X(89)90158-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510X(89)90158-5</ArticleId><ArticleId IdType="pubmed">2809628</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi H, Oppenheimer EA. ALS patients on TPPV: totally locked-in state, neurologic findings and ethical implications. Neurology. 2003;61:135&#x2013;137. doi: 10.1212/01.WNL.0000069925.02052.1F.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.WNL.0000069925.02052.1F</ArticleId><ArticleId IdType="pubmed">12847177</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi H, Kato S, Kawada T, Tsubaki T. Amyotrophic lateral sclerosis: oculomotor function in patients in respirators. Neurology. 1987;37:1431&#x2013;1432. doi: 10.1212/WNL.37.8.1431-a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.37.8.1431-a</ArticleId><ArticleId IdType="pubmed">3475594</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma R, et al. Oculomotor dysfunction in amyotrophic lateral sclerosis: a comprehensive review. Arch. Neurol. 2011;68:857&#x2013;861. doi: 10.1001/archneurol.2011.130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2011.130</ArticleId><ArticleId IdType="pubmed">21747027</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaunak S, et al. Oculomotor function in amyotrophic lateral sclerosis: evidence for frontal impairment. Ann. Neurol. 1995;38:38&#x2013;44. doi: 10.1002/ana.410380109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410380109</ArticleId><ArticleId IdType="pubmed">7611722</ArticleId></ArticleIdList></Reference><Reference><Citation>Veronese S, Valle A, Chio A, Calvo A, Oliver D. The last months of life of people with amyotrophic lateral sclerosis in mechanical invasive ventilation: a qualitative study. Amyotroph. Lateral Scler. Frontotemporal Degener. 2014;15:499&#x2013;504. doi: 10.3109/21678421.2014.913637.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.913637</ArticleId><ArticleId IdType="pubmed">24863495</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu T, et al. Circulatory collapse and sudden death in respirator-dependent amyotrophic lateral sclerosis. J. Neurol. Sci. 1994;124:45&#x2013;55. doi: 10.1016/0022-510X(94)90009-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510X(94)90009-4</ArticleId><ArticleId IdType="pubmed">7931421</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, Pradat PF, Ludolph AC, Loeffler JP. Energy metabolism in amyotrophic lateral sclerosis. Lancet Neurol. 2011;10:75&#x2013;82. doi: 10.1016/S1474-4422(10)70224-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70224-6</ArticleId><ArticleId IdType="pubmed">21035400</ArticleId></ArticleIdList></Reference><Reference><Citation>Holm T, et al. Severe loss of appetite in amyotrophic lateral sclerosis patients: online self-assessment study. Interact. J. Med. Res. 2013;2:e8. doi: 10.2196/ijmr.2463.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/ijmr.2463</ArticleId><ArticleId IdType="pmc">PMC3632382</ArticleId><ArticleId IdType="pubmed">23608722</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu T. Sympathetic hyperactivity and sympathovagal imbalance in amyotrophic lateral sclerosis. Eur. Neurol. Rev. 2013;8:46&#x2013;50. doi: 10.17925/ENR.2013.08.01.46.</Citation><ArticleIdList><ArticleId IdType="doi">10.17925/ENR.2013.08.01.46</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasarskis EJ, et al. Estimating daily energy expenditure in individuals with amyotrophic lateral sclerosis. Am. J. Clin. Nutr. 2014;99:792&#x2013;803. doi: 10.3945/ajcn.113.069997.</Citation><ArticleIdList><ArticleId IdType="doi">10.3945/ajcn.113.069997</ArticleId><ArticleId IdType="pmc">PMC3953880</ArticleId><ArticleId IdType="pubmed">24522445</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu T, et al. The measurement and estimation of total energy expenditure in Japanese patients with ALS: a doubly labelled water method study. Amyotroph. Lateral Scler. Frontotemporal Degener. 2017;18:37&#x2013;45. doi: 10.1080/21678421.2016.1245756.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2016.1245756</ArticleId><ArticleId IdType="pubmed">27892703</ArticleId></ArticleIdList></Reference><Reference><Citation>Vercruysse P, et al. Alterations in the hypothalamic melanocortin pathway in amyotrophic lateral sclerosis. Brain. 2016;139:1106&#x2013;1122. doi: 10.1093/brain/aww004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aww004</ArticleId><ArticleId IdType="pubmed">26984187</ArticleId></ArticleIdList></Reference><Reference><Citation>Vercruysse P, Vieau D, Blum D, Petersen A, Dupuis L. Hypothalamic alterations in neurodegenerative diseases and their relation to abnormal energy metabolism. Front. Mol. Neurosci. 2018;11:2. doi: 10.3389/fnmol.2018.00002.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00002</ArticleId><ArticleId IdType="pmc">PMC5780436</ArticleId><ArticleId IdType="pubmed">29403354</ArticleId></ArticleIdList></Reference><Reference><Citation>Scherz B, et al. mTh1 driven expression of hTDP-43 results in typical ALS/FTLD neuropathological symptoms. PLoS One. 2018;13:e0197674. doi: 10.1371/journal.pone.0197674.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0197674</ArticleId><ArticleId IdType="pmc">PMC5963763</ArticleId><ArticleId IdType="pubmed">29787578</ArticleId></ArticleIdList></Reference><Reference><Citation>Cykowski MD, Takei H, Schulz PE, Appel SH, Powell SZ. TDP-43 pathology in the basal forebrain and hypothalamus of patients with amyotrophic lateral sclerosis. Acta Neuropathol. Commun. 2014;2:171. doi: 10.1186/s40478-014-0171-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-014-0171-1</ArticleId><ArticleId IdType="pmc">PMC4297460</ArticleId><ArticleId IdType="pubmed">25539830</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorges M, et al. Hypothalamic atrophy is related to body mass index and age at onset in amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 2017;88:1033&#x2013;1041. doi: 10.1136/jnnp-2017-315795.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-315795</ArticleId><ArticleId IdType="pubmed">28596251</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, et al. A randomized, double blind, placebo-controlled trial of pioglitazone in combination with riluzole in amyotrophic lateral sclerosis. PLoS One. 2012;7:e37885. doi: 10.1371/journal.pone.0037885.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0037885</ArticleId><ArticleId IdType="pmc">PMC3371007</ArticleId><ArticleId IdType="pubmed">22715372</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi K, et al. Clinicopathological characteristics of patients with amyotrophic lateral sclerosis resulting in a totally locked-in state (communication Stage V) Acta Neuropathol. Commun. 2016;4:107. doi: 10.1186/s40478-016-0379-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0379-3</ArticleId><ArticleId IdType="pmc">PMC5045653</ArticleId><ArticleId IdType="pubmed">27716404</ArticleId></ArticleIdList></Reference><Reference><Citation>Oyanagi K, et al. Marked preservation of the visual and olfactory pathways in ALS patients in a totally locked-in state. Clin. Neuropathol. 2015;34:267&#x2013;274. doi: 10.5414/NP300859.</Citation><ArticleIdList><ArticleId IdType="doi">10.5414/NP300859</ArticleId><ArticleId IdType="pubmed">26042590</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishihira Y, et al. Sporadic amyotrophic lateral sclerosis: two pathological patterns shown by analysis of distribution of TDP-43-immunoreactive neuronal and glial cytoplasmic inclusions. Acta Neuropathol. 2008;116:169&#x2013;182. doi: 10.1007/s00401-008-0385-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-008-0385-z</ArticleId><ArticleId IdType="pubmed">18481073</ArticleId></ArticleIdList></Reference><Reference><Citation>Warabi, Y., Hayashi, K., Nagao, M. &amp; Shimizu, T. Marked widespread atrophy of the cerebral cortex and brainstem in sporadic amyotrophic lateral sclerosis in a totally locked-in state. BMJ Case Rep. 2017 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5318601</ArticleId><ArticleId IdType="pubmed">28196825</ArticleId></ArticleIdList></Reference><Reference><Citation>Ichihara N, et al. Energy requirement assessed by doubly-labeled water method in patients with advanced amyotrophic lateral sclerosis managed by tracheotomy positive pressure ventilation. Amyotroph. Lateral Scler. 2012;13:544&#x2013;549. doi: 10.3109/17482968.2012.699968.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2012.699968</ArticleId><ArticleId IdType="pubmed">22889175</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu T, Hayashi H, Tanabe H. Energy metabolism of ALS patients under mechanical ventilation and tube feeding. Rinsho Shinkeigaku. 1991;31:255&#x2013;259.</Citation><ArticleIdList><ArticleId IdType="pubmed">1909943</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishiyama Y, Abe K, Tokunaga J, Numayama T. Metabolic syndrome in advanced amyotrophic lateral sclerosis patients with tracheostomy-invasive ventilation. Neurol. Clin. Neurosci. 2019;7:174&#x2013;179. doi: 10.1111/ncn3.12289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ncn3.12289</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuda C, et al. Macroglossia in advanced amyotrophic lateral sclerosis. Muscle Nerve. 2016;54:386&#x2013;390. doi: 10.1002/mus.25058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.25058</ArticleId><ArticleId IdType="pubmed">26816340</ArticleId></ArticleIdList></Reference><Reference><Citation>McKee HR, Escott E, Damm D, Kasarskis E. Macroglossia in amyotrophic lateral sclerosis. JAMA Neurol. 2013;70:1432&#x2013;1435. doi: 10.1001/jamaneurol.2013.3138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2013.3138</ArticleId><ArticleId IdType="pubmed">24042440</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu T, et al. Hyperosmolar hyperglycemic state in advanced amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 2011;12:379&#x2013;381. doi: 10.3109/17482968.2010.539234.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2010.539234</ArticleId><ArticleId IdType="pubmed">21126160</ArticleId></ArticleIdList></Reference><Reference><Citation>Atsuta N, et al. Age at onset influences on wide-ranged clinical features of sporadic amyotrophic lateral sclerosis. J. Neurol. Sci. 2009;276:163&#x2013;169. doi: 10.1016/j.jns.2008.09.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2008.09.024</ArticleId><ArticleId IdType="pubmed">18962725</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabkin J, et al. Japanese and American ALS patient preferences regarding TIV (tracheostomy with invasive ventilation): a cross-national survey. Amyotroph. Lateral Scler. Frontotemporal Degener. 2014;15:185&#x2013;191. doi: 10.3109/21678421.2014.896928.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.896928</ArticleId><ArticleId IdType="pubmed">24720451</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>